WES of mCRC xenografts under cetuximab treatment, placebo or after treatment release
|Study ID||Alternative Stable ID||Type|
Determine if cetuximab treatment selects any pre-existing resistant subclones or if the resistant cells, which in vivo determines residual disease, are driven by plasticity effects not linked to mutations.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
|EGAD00001005186||WES on cetuximab treated, untreated and release samples of two metastatic colorectal xenografts. First case: 3 cetuximab treated samples, 3 placebo and 3 release. Second case: 2 cetuximab treated samples, 2 placebo and 3 release. Paired fastq.||Illumina HiSeq 2500||16|
Who archives the data?
There are no publications available